Acute Gastroenteritis (AGE) and Acute Respiratory Illness (ARI) in Children

Enhanced Active Surveillance of Pediatric Infectious Disease and Vaccine by the New Vaccine Surveillance Network

Protocol Description

The goals of this multi-center observational study by the New Vaccine Surveillance Network (NVSN) are to help researchers learn more about the germs that cause acute gastroenteritis (AGE) and acute respiratory illness (ARI) in children and to improve our understanding of how well vaccines prevent these illnesses.

Eligibility Criteria

Children of both genders, under the age of 18, who are admitted to UPMC Children’s Hospital of Pittsburgh or who are being treated in the Emergency department for respiratory illness or for nausea, vomiting, and diarrhea may be eligible for enrollment into the study based on inclusion criteria.
Males and Females: Up through 17 years of age


Researchers will collect information on the child’s health, symptoms, vaccination record, and demographics. For analytical purposes, certain biologic samples will also be collected, determined by whether the child is enrolled in the AGE or ARI component of the study.
Visits: 1
Duration: Not applicable

Status: Open to Enrollment

Source(s) of Support

Centers for Disease Control and Prevention

Primary Investigator

John Williams, MD

Contact Information

For more information about the study or registration, please contact:
Clinical Research Nurse Coordinator Nicole Naylor (Machi), BSN, RN, CPEN